DrugPatentWatch Database Preview
LEXAPRO Drug Profile
» See Plans and Pricing
Which patents cover Lexapro, and what generic alternatives are available?
Lexapro is a drug marketed by Allergan and is included in two NDAs. There are two patents protecting this drug and two Paragraph IV challenges.
This drug has fifty-six patent family members in thirty-eight countries.
The generic ingredient in LEXAPRO is escitalopram oxalate. There are twenty-six drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the escitalopram oxalate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lexapro
A generic version of LEXAPRO was approved as escitalopram oxalate by AMNEAL PHARMS on March 14th, 2012.
Summary for LEXAPRO
International Patents: | 56 |
US Patents: | 2 |
Applicants: | 1 |
NDAs: | 2 |
Suppliers / Packagers: | 3 |
Bulk Api Vendors: | 75 |
Clinical Trials: | 92 |
Patent Applications: | 567 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for LEXAPRO |
Drug Sales Revenues: | Drug sales revenues for LEXAPRO |
What excipients (inactive ingredients) are in LEXAPRO? | LEXAPRO excipients list |
DailyMed Link: | LEXAPRO at DailyMed |



Recent Clinical Trials for LEXAPRO
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Columbia University | Phase 4 |
Alto Neuroscience | Phase 4 |
Shanghai Mental Health Center | N/A |
Pharmacology for LEXAPRO
Drug Class | Serotonin Reuptake Inhibitor |
Mechanism of Action | Serotonin Uptake Inhibitors |
Paragraph IV (Patent) Challenges for LEXAPRO
Tradename | Dosage | Ingredient | NDA | Submissiondate |
---|---|---|---|---|
LEXAPRO | TABLET;ORAL | escitalopram oxalate | 021323 | 2005-08-17 |
LEXAPRO | TABLET;ORAL | escitalopram oxalate | 021323 | 2005-03-30 |
US Patents and Regulatory Information for LEXAPRO
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Allergan | LEXAPRO | escitalopram oxalate | SOLUTION;ORAL | 021365-001 | Nov 27, 2002 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
Allergan | LEXAPRO | escitalopram oxalate | TABLET;ORAL | 021323-003 | Aug 14, 2002 | AB | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||
Allergan | LEXAPRO | escitalopram oxalate | TABLET;ORAL | 021323-002 | Aug 14, 2002 | AB | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | ||
Allergan | LEXAPRO | escitalopram oxalate | TABLET;ORAL | 021323-001 | Aug 14, 2002 | AB | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | ||
Allergan | LEXAPRO | escitalopram oxalate | TABLET;ORAL | 021323-001 | Aug 14, 2002 | AB | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | ||
Allergan | LEXAPRO | escitalopram oxalate | TABLET;ORAL | 021323-003 | Aug 14, 2002 | AB | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||
Allergan | LEXAPRO | escitalopram oxalate | TABLET;ORAL | 021323-002 | Aug 14, 2002 | AB | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LEXAPRO
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Allergan | LEXAPRO | escitalopram oxalate | SOLUTION;ORAL | 021365-001 | Nov 27, 2002 | Start Trial | Start Trial |
Allergan | LEXAPRO | escitalopram oxalate | TABLET;ORAL | 021323-003 | Aug 14, 2002 | Start Trial | Start Trial |
Allergan | LEXAPRO | escitalopram oxalate | TABLET;ORAL | 021323-001 | Aug 14, 2002 | Start Trial | Start Trial |
Allergan | LEXAPRO | escitalopram oxalate | TABLET;ORAL | 021323-002 | Aug 14, 2002 | Start Trial | Start Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LEXAPRO
Country | Patent Number | Estimated Expiration |
---|---|---|
Montenegro | P2108 | Start Trial |
China | 1536997 | Start Trial |
Finland | 20041359 | Start Trial |
Japan | 5719811 | Start Trial |
South Africa | 200309684 | Start Trial |
Colombia | 5560540 | Start Trial |
Austria | 286730 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for LEXAPRO
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0347066 | 90999 | Luxembourg | Start Trial | |
0347066 | 2002C/039 | Belgium | Start Trial | PRODUCT NAME: ESCITALOPRAM. OXALAT. (INN) ESCITALOPRAM; NATL. REGISTRATION NO/DATE: 7004 IE10 F 3 20020729; FIRST REGISTRATION: SE 17084 20011207 |
0347066 | 10399030 | Germany | Start Trial | PRODUCT NAME: ESCITALOPRAMOXALAT; NAT. REGISTRATION NO/DATE: 55880.00.00 55880.01.00 55880.02.00 55880.03.00 55884.00.00 55884.01.00 55884.02.00 55884.03.00 55888.00.00 55888.01.00 55888.02.00 55888.03.00 20030408 FIRST REGISTRATION: SCHWEDEN 17084 17085 17086 17087 20011207 |
0347066 | C300155 | Netherlands | Start Trial | PRODUCT NAME: ESCITALOPRAM, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVA ARDBAAR ZUURADDITIEZOUT, IN HET BIJZONDER ESCITALOPRAMOXALAAT; REGISTRATION NO/DATE: RVG 30490 - RVG 30497 20040427 |
0347066 | SZ 42/2002 | Austria | Start Trial | |
0347066 | SPC/GB02/049 | United Kingdom | Start Trial | PRODUCT NAME: ESCITALOPRAM OXALATE; REGISTERED: SE 17084/85/86/87 20011207; UK PL 13761/0008 20020610; UK PC 13761/0009 20020610; UK PL 13761/0010 20020610; UK PL 13761/0011 20020610; UK PL 13761/0012 20020610; UK PL 13761/0013 20020610; UK PL 13761/00014 20020610; UK PL 13761/0015 20020610 |
0347066 | 42/2002 | Austria | Start Trial | PRODUCT NAME: ESCITALOPRAM UND DESSEN NICHT-TOXISCHE SAEUREADDITIONSSALZE; NAT. REGISTRATION NO/DATE: 1-24549, 1-24550, 1-24551, 1-24552 20020618; FIRST REGISTRATION: SE 17084, 17085, 17086,17087 20011207 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |